These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 26318312)

  • 1. MAPK/ERK signaling pathway-induced hyper-O-GlcNAcylation enhances cancer malignancy.
    Zhang X; Ma L; Qi J; Shan H; Yu W; Gu Y
    Mol Cell Biochem; 2015 Dec; 410(1-2):101-10. PubMed ID: 26318312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
    Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
    Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
    Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
    Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressed OGT expression inhibits cell proliferation while inducing cell apoptosis in bladder cancer.
    Wang L; Chen S; Zhang Z; Zhang J; Mao S; Zheng J; Xuan Y; Liu M; Cai K; Zhang W; Guo Y; Zhai W; Yao X
    BMC Cancer; 2018 Nov; 18(1):1141. PubMed ID: 30453909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmented TME
    Moriwaki K; Asahi M
    Mol Cancer Res; 2017 Sep; 15(9):1287-1298. PubMed ID: 28536142
    [No Abstract]   [Full Text] [Related]  

  • 6. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
    Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
    Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells.
    Goldberg H; Whiteside C; Fantus IG
    Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E713-26. PubMed ID: 21712532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.
    Zhang N; Chen X
    Biotechnol Appl Biochem; 2016 Nov; 63(6):841-851. PubMed ID: 26333304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O-GlcNAcylation involvement in high glucose-induced cardiac hypertrophy via ERK1/2 and cyclin D2.
    Ding F; Yu L; Wang M; Xu S; Xia Q; Fu G
    Amino Acids; 2013 Aug; 45(2):339-49. PubMed ID: 23665912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F; Ciccarelli C; Zani BM
    Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis.
    Zhang D; Cai Y; Chen M; Gao L; Shen Y; Huang Z
    Inflamm Res; 2015 Dec; 64(12):943-52. PubMed ID: 26407569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-GlcNAcylation regulates breast cancer metastasis via SIRT1 modulation of FOXM1 pathway.
    Ferrer CM; Lu TY; Bacigalupa ZA; Katsetos CD; Sinclair DA; Reginato MJ
    Oncogene; 2017 Jan; 36(4):559-569. PubMed ID: 27345396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
    Gysin S; Lee SH; Dean NM; McMahon M
    Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.
    Lynch TP; Ferrer CM; Jackson SR; Shahriari KS; Vosseller K; Reginato MJ
    J Biol Chem; 2012 Mar; 287(14):11070-81. PubMed ID: 22275356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aβ-affected pathogenic induction of S-nitrosylation of OGT and identification of Cys-NO linkage triplet.
    Ryu IH; Lee KY; Do SI
    Biochim Biophys Acta; 2016 May; 1864(5):609-21. PubMed ID: 26854602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-GlcNAc transferase activates stem-like cell potential in hepatocarcinoma through O-GlcNAcylation of eukaryotic initiation factor 4E.
    Cao B; Duan M; Xing Y; Liu C; Yang F; Li Y; Yang T; Wei Y; Gao Q; Jiang J
    J Cell Mol Med; 2019 Apr; 23(4):2384-2398. PubMed ID: 30677218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion formation correlates with activation of translation-regulating protein 4E-BP and neuronal transcription factor Elk1.
    Allard EK; Grujic M; Fisone G; Kristensson K
    Neurobiol Dis; 2013 Oct; 58():116-22. PubMed ID: 23742760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy.
    Mi W; Gu Y; Han C; Liu H; Fan Q; Zhang X; Cong Q; Yu W
    Biochim Biophys Acta; 2011 Apr; 1812(4):514-9. PubMed ID: 21255644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
    Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
    Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.